Skip to main content

Table 1 Participant baseline characteristics

From: A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome

Sex Placebo (N = 10)
N
F: 5
M: 5
Range Oxytocin (N = 8)
N
F: 4
M: 4
Range Total (N = 18)
N
F: 9
M: 9
Range p-value
Mean (SD)   Mean (SD)   Mean (SD)  
Age (years) 9.8 (3.6) 6–17 6.8 (1.4) 5–9 8.4 (3.2) 5–17 0.055
Baseline ABC-SW 20.1 (6.1) 12–30 14 (3.4) 12–20 17.4 (5.9) 12–30 0.012*
Verbal DQ 14.9 (12.8) 4–46 26.4 (21.3) 8–61 20 (17.6) 4–61 0.203
Nonverbal DQ 20.1 (11.7) 4–42 26.1 (13.1) 11–50 22.7 (12.3) 4–50 0.408
Full Scale DQ 17.4 (11.8) 5–44 26.3 (16.7) 10–50 21.4 (14.5) 5–50 0.173
  1. ABC-SW Aberrant Behavior Checklist Social Withdrawal subscale; DQ developmental quotient; F female; M male; N sample size; SD standard deviation